Ausgabe 4/2022
Inhalt (17 Artikel)
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients
Gwyneth Kong, Nicholas W. S. Chew, Cheng Han Ng, Yip Han Chin, Rebecca Zeng, Roger Foo, Koo Hui Chan, Adrian Fatt-Hoe Low, Chi-Hang Lee, Mark Yan-Yee Chan, Tiong-Cheng Yeo, Huay-Cheem Tan, Poay-Huan Loh
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
Sara R. Vazquez, Aaron S. Wilson, Daniel M. Witt
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
Ersan Atahan, Emine Karabul, Ruveyda Akcin, Buket Caliskaner Ozturk, Aysegul Gencer, Bekir Kocazeybek
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison
Samantha Pasca, Cojutti PierGiorgio, Federico Pea
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia
Asmaa Albuloushi, Megan Rhoten, Julie Kelly, Katelyn W. Sylvester, Jessica Grandoni, Jean M. Connors
Post-thrombolytic coagulopathy and complications in patients with pulmonary embolism treated with fixed-dose systemic alteplase
Matthew P. Lillyblad, Ghaziuddin A. Qadri, Brynn E. Weise, Claire S. Smith, Catherine St. Hill, David M. Tierney, Roman R. Melamed
Prescribing of anticoagulation for atrial fibrillation in primary care
Kathryn A. Martinez, Mark H. Eckman, Matthew A. Pappas, Michael B. Rothberg
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
Alessandra Serrao, Francesco Malfona, Giovanni Manfredi Assanto, Maria Gabriela Chavez Orellana, Cristina Santoro, Antonio Chistolini
In-hospital prognosis of malignancy-related pulmonary embolism: an analysis of the national inpatient sample 2016–2018
Dae Yong Park, Seokyung An, Ibrahim Kashoor, Olisa Ezegwu, Shweta Gupta
A survey of internists’ recommendations for aspirin in older adults and barriers to evidence-based use
Jordan K. Schaefer, Geoffrey D. Barnes, Jeremy B. Sussman, Sameer D. Saini, Tanner J. Caverly, Susan Read, Brian J. Zikmund-Fisher, Jacob E. Kurlander
Biomarkers associated with coronary high-risk plaques
Akihiro Nakajima, Peter Libby, Satoru Mitomo, Haruhito Yuki, Makoto Araki, Lena Marie Seegers, Iris McNulty, Hang Lee, Midori Ishibashi, Kazuna Kobayashi, Jouke Dijkstra, Toru Ouchi, Hirokazu Onishi, Hiroto Yabushita, Satoshi Matsuoka, Hiroyoshi Kawamoto, Yusuke Watanabe, Kentaro Tanaka, Shengpu Chou, Tomohiko Sato, Toru Naganuma, Masaaki Okutsu, Satoko Tahara, Naoyuki Kurita, Shotaro Nakamura, David J. Kuter, Sunao Nakamura, Ik-Kyung Jang
Activated clotting time in inpatient diagnostic and interventional settings
Heidi Dalton, Michael Martin, Pamela Garcia-Filion, David Shavelle, Pei-Hsiu Huang, Justin Clark, Sean Beinart, Andrew Israel, Nichole Korpi-Steiner
Increased risk of venous thromboembolism among patients with familial Mediterranean fever
Omer Gendelman, Ariel J Feifel, Avishai M Tsur, Doron Comanhester, Arnon D Cohen, Howard Amital
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity
Titilope Olanipekun, Temidayo Abe, Valery Effoe, Abimbola Chris-Olaiya, Isaac Biney, Pramod Guru, Charles Ritchie, Devang Sanghavi
Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review
Sanad Oulkadi, Benjamin Peters, Anne-Sophie Vliegen
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study
Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen, Deepa Malhotra, Birol Emir, Cristina Russ, Xiaoyan Li, Theodore C. Lee, Mauricio Ferri, Danny Wiederkehr, Maya Reimbaeva, Geoffrey D. Barnes, Gregory Piazza